Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Gilead Sciences to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11


Print article Print article
© Business Wire 2009
2009-11-04 22:49:01 -

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the 18 th Annual Credit Suisse Healthcare Conference in Phoenix.

John C. Martin, PhD, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company on Wednesday, November 11 at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time).

To access the live webcast or a replay via the internet log on to www.gilead.com : .

Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead


Gilead Sciences is a

biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com : or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Gilead Sciences, Inc.Susan Hubbard, 650-522-5715Investor
Relations


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2012 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser